|
|
|
|
| LEADER |
03393nam a22003015i 4500 |
| 001 |
978-1-59259-334-7 |
| 005 |
20190618091931.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2003 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781592593347
|
| 024 |
7 |
|
|a 10.1385/1592593348
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Recombinant Antibodies for Cancer Therapy
|b Methods and Protocols /
|c edited by Martin Welschof, Jürgen Krauss.
|
| 250 |
|
|
|a 1st ed. 2003.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2003.
|
| 300 |
|
|
|a XIV, 481 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Molecular Biology,
|v 207
|
| 505 |
0 |
|
|a Generation of Antibody Molecules Through Antibody Engineering -- Application of Recombinant Antibodies in Cancer Patients -- Hybridoma-Derived Antibodies -- DNA Immunization as a Means to Generate Antibodies to Proteins -- Chimerization of a Monoclonal Antibody for Treating Hodgkin's Lymphoma -- Humanization of Monoclonal Antibodies by CDR Grafting -- Recombinant Antibody Fragments from Phagemid-Displayed Antibody Repertoires -- Generation and Screening of a Modular Human scFv Expression Library from Multiple Donors -- Construction of Semisynthetic Antibody Libraries -- Single-Domain VH Antibody Fragments from a Phage Display Library -- Isolation of Human Fab Fragments Against Ovarian Carcinoma Using Guided Selection -- Human Recombinant Fab Antibodies with T-Cell Receptor-Like Specificities Generated from Phage Display Libraries -- Engineering Hot Spots for Affinity Enhancement of Antibodies -- Simultaneous Humanization and Affinity Optimization of Monoclonal Antibodies -- Tailoring Kinetics of Antibodies Using Focused Combinatorial Libraries -- Antibody Fragments with Additional Properties -- Engineering scFvs for Improved Stability -- Recombinant Single-Chain and Disulfide-Stabilized Fv Immunotoxins for Cancer Therapy -- Generation of Recombinant Immunotoxins for Specific Targeting of Tumor-Related Peptides Presented by MHC Molecules -- Construction and Characterization of RNase-Based Targeted Therapeutics -- Bispecific Diabodies for Cancer Therapy -- Generation and Characterization of Bispecific Tandem Diabodies for Tumor Therapy -- Generation of Recombinant Multimeric Antibody Fragments for Tumor Diagnosis and Therapy -- Construction and Characterization of Minibodies for Imaging and Therapy of Colorectal Carcinomas -- Generation, Expression, and Monitoring of Recombinant Immune Receptors for Use in Cellular Immunotherapy -- Tailoring Natural Effector Functions -- Single-Chain Fv-Based Affinity Purification of the Cellular Stress Protein gp96 for Vaccine Development -- Recombinant Adenoviruses for In Vivo Expression of Antibody Fragments -- Large Scale Production of Recombinant Antibodies for Clinical Application -- Production of Antibody Fragments in a Bioreactor -- Large Scale Production of Recombinant Antibodies by Utilizing Cellulose-Binding Domains -- Production of Tumor-Specific Antibodies in Tobacco.
|
| 650 |
|
0 |
|a Oncology .
|
| 650 |
1 |
4 |
|a Oncology.
|
| 700 |
1 |
|
|a Welschof, Martin.
|e editor.
|
| 700 |
1 |
|
|a Krauss, Jürgen.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1385/1592593348
|